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Abstract - Tanaceti partheni, Hypericum perforatum and propolis have been widely used for centuries and are well-docu-
mented medicinal plants and natural product. In this study, we investigated the antiproliferative effects of water extracts 
of ethanolic dry extracts of two different medicinal plants (Tanaceti partheni and Hypericum perforatum) and propolis 
on HeLa cells. The Tanaceti partheni extract exhibited mild cytotoxic activity. The IC50 was 153.71 µg/mL. The extract of 
Hypericum perforatum did not show active cytotoxic activity against HeLa cells (IC50 >200 μg/mL). Regarding the anti-
proliferative effects of Hypericum perforatum, our results are not in correlation with the results of other authors, prob-
ably because different Hypericum species and different human cancer cell lines were used. The extract of propolis did not 
show active cytotoxic activity against HeLa cells (IC50 = 1.08 ± 0.01 mg/mL). The weak antiproliferative effect of propolis 
on HeLa cells is either due to the use of a low concentration of propolis extracted in weakly polar solvents, or the use of 
propolis collected in the autumn.
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INTRODUCTION
Cancer  is  a  major  public  health  problem  world-
wide. In 2009, approximately 1 470 000 new cases 
in the United States have been diagnosed and more 
than 560 000 people died from cancers (Jemal et al., 
2009). Cancer is the second leading cause of death in 
many countries, as it is in Serbia. Lifestyle and/or en-
vironmental factors, especially dietary factors, play 
regulatory roles in the formation of cancer (Zi-Luan 
et al., 2011). The major causes are smoking, dietary 
imbalances, hormones and chronic infections lead-
ing to chronic inflammation (Ames et al., 1995). The 
estimated worldwide incidence of different carcino-
mas is about 10 million; half of which are in devel-
oping countries (Cozzi et al., 2004). Chemotherapy, 
as a major treatment modality used for the control 
of advanced stages of malignancies and as a pro-
phylactic against possible metastasis, exhibits severe 
toxicity on normal tissues (Pandey and Madhuri, 
2006). Among cancer patients in the USA, the use 
of complementary and alternative medicine ranges 
between 30-75% (Richardson, 2001). This in turn 
justifies the interest in the search for possible anti-
cancer agents from the flora of different countries. 
Over  the  past  decade,  herbal  medicines  have 
been accepted universally, and they have an impact 706 DESANKA CENIĆ-MILOŠEVIĆ ET AL.
on both world health and international trade. Hence, 
medicinal plants continue to play an important role 
in the healthcare systems of a large number of the 
world’s  populations  (Akerele,  1988).  Traditional 
medicine is widely used in Serbia as well.
The use of medicinal plants and propolis are be-
coming increasingly appreciated in suppressing can-
cer growth (Orsolic and Basic, 2003; Waladkhani and 
Clemens, 1998) and cancer prevention (Pan and Ho, 
2008). Tanaceti partheni, Hypericum perforatum and 
propolis have been widely used and well-document-
ed medicinal plants and natural product for centuries 
(Hansel and Sticher, 2002; Weiss, 1988). Antifungal 
(Decosterd et al., 1986), antibacterial (Ishiguro et al., 
1986), antiviral (Jacobson et al., 2001) and anticancer 
(Jayasuriya et al., 1989) compounds have been iso-
lated from Hypericum species. Propolis has been used 
in folk medicine from ancient times and has recently 
become a subject of special interest in the area of on-
cology research as a source of valuable compounds 
for the prevention and cancer treatment (Galvao et 
al., 2007). 
In this study, we investigated the antiproliferative 
effects of water extracts of ethanolic dry extracts of 
two different medicinal plants (Tanaceti partheni and 
Hypericum perforatum) and propolis on cell lines de-
rived from human cervix adenocarcinoma (HeLa) 
cells.
MATERIALS AND METHODS
Materials
Tanacetum parthenium was obtained from the area of 
Pančevo in Serbia, Hypericum perforatum from free-
growing plants in central Serbia and crude propolis 
was collected from one bee colony (in the region of 
Raška) during one time-frame (autumn), to main-
tain the homogeneity of the raw material. 
Preparation of extracts
The first extraction was done in a percolator us-
ing 70% ethanol. Low-pressure evaporation of the 
extract was done following extraction. A 2l glass 
percolator was first lined with cotton wool. Sub-
sequently, it was filled with precut and sifted plant 
and covered with 70% ethanol. The content was left 
to macerate for at least 16 h. Following maceration, 
the extract was poured out of the percolator at the 
speed of 2 l/h. The amount of poured extract was six 
times the volume of the starting material (1:6 ex-
tract). The extract was then stored for the next 3-5 
days, filtered through a series of Whatman-filters 
and finally passed through a 0.22 μm filter (Milli-
pore, Billerica, MA). Subsequently, the extract was 
evaporated in a rotational vacuum evaporator until 
a dry powder was obtained. The temperature in the 
evaporator was kept below 65oC under a pressure of 
15-25 mbar.
Propolis was extracted by the addition of 500 ml 
of ethanol to 150 g of propolis. The extraction proc-
ess lasted for 48 h, after which 465 ml of filtrate was 
obtained. 
In the order to obtain water-soluble components, 
a second extraction was done. The dry ethanolic ex-
tracts were weighed and mixed with physiological sa-
line to 10 mg/mL. These suspensions were put in the 
dark at room temperature for 24 h; they were shaken 
for 3 h. The supernatants were filtered through 0.22 
m filter paper. The obtained water extracts were used 
as stock solutions and were diluted with nutrient me-
dium to the various working concentrations.
Cell line
Human  cervix  adenocarcinoma  HeLa  cells  were 
obtained from the American Type Culture Collec-
tion (ATCC) (Manassas, VA, USA). HeLa cells were 
maintained in the recommended nutrition medium: 
RPMI  1640  medium  supplemented  with  100  g/L 
heat-inactivated (560C) fetal bovine serum (FBS), 3 
mmol/L L-glutamine, 100 g/mL streptomycin, 100 
IU/mL penicillin and 25 mmol/L 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic  acid  (HEPES)  and  ad-
justed  to  pH  7.2  with  bicarbonate  solution.  Cells 
were grown in a humidified atmosphere of 5% CO2 
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Treatment of the cell line
HeLa (2 000 cells per well) cells were seeded into 
96-well microtiter plates; 24 h later, after the cell ad-
herence, five different double-diluted concentrations 
of water extracts were added to the wells. The final 
concentrations of extracts applied to cells were 12.5, 
25, 50, 100 and 200 μg/ml; 50% propolis dissolved in 
1% ethanol was finally diluted with nutrient medium 
120 times and applied to target cells in final concen-
trations of 0.5, 1, 2 and 4 mg/ml. In the control wells, 
only the nutrient medium was added to the cells. The 
cultures were incubated for 72 h.
Determination of cell survival
The  effect  of  extracts  on  cell  survival  was  deter-
mined by the microculture tetrazolium test (MTT) 
according  to  Mosmann  (1983)  with  modification 
by Ohno and Abe (1991), 72 h after addition of the 
compounds. Briefly, 20 μL of MTT solution (5 mg/
ml  phosphate-buffered  saline)  was  added  to  each 
well. Samples were incubated for a further 4 h under 
the same conditions. Then 100 μl of 100 g/l sodium 
dodecyl sulfate was added to dissolve formazan, the 
product from the conversion of MTT dye by viable 
cells. The number of viable cells in each well was pro-
portional to the intensity of absorbance, read in an 
ELISA plate reader at 570 nm 24 h later. To deter-
mine cell survival (%), the A of a sample with cells 
grown in the presence of various concentrations of 
the investigated extracts was divided by the control 
optical density (the A of control cells grown only in 
nutrient medium) and multiplied by 100. IC50 is the 
concentration of an agent that inhibits cell survival 
by 50%. The values of IC50 are means from two meas-
urements, each done in triplicate. IC50 were estab-
lished from dose-dependent data with using Graph-
pad Prism Ver 3.0 software.
RESULTS
In vitro antitumor activity
The cytotoxic action of Tanaceti partheni, Hyperi-
cum perforatum and propolis extracts were tested on 
HeLa cells. The IC50 values of the studied extracts are 
presented in Table 1, while Fig. 1 depicts the cyto-
toxic curves from MTT assay showing the survival of 
HeLa cell grown for 72 h in the presence of increas-
ing concentrations of extracts. The Tanaceti partheni 
extract exhibited mild cytotoxic activity. The IC50 on 
HeLa cell lines was 153.71 µg/ml. The extracts of Hy-
pericum perforatum and propolis did not show active 
cytotoxic activity against the HeLa cell lines (IC50 > 
200 μg/ml; IC50 = 1.08 ± 0.01 mg/ml, respectively). 
Light microscopy
Results of microscopic examination (Carl Zeiss in-
verted microscopy, with total magnification 630) of 
investigated  HeLa  cells  after  72-h  treatment  with 
Tanaceti partheni, Hypericum perforatum and propo-
lis extracts are shown in Fig. 2. Extracts at a concen-
tration of 200 µg/ml (2.0 mg/ml) induced rounding, 
detachment and decreased the number of HeLa cells, 
as compared to control cells.
DISCUSSION
In this study, the antiproliferative effects of ethanolic 
dry extracts of two different medicinal plants, Tan-
aceti partheni and Hypericum perforatum, and 1% 
ethanolic extract of propolis on HeLa cells were in-
vestigated. 
Tanacetum parthenium (feverfew) was native to 
Eurasia;  specifically  the  Balkan  Peninsula,  Anato-
lia and the Caucasus, but cultivation has spread it 
around the world and it is now found in Europe, the 
Mediterranean, North America and Chile (Jeffrey, 
2001). The plant has been used as herbal treatment 
to reduce fever and to treat headaches, arthritis and 
digestive problems; scientific evidence does not sup-
port anything beyond a placebo effect (Pareek et al., 
2009). The active ingredients in Tanaceti partheni in-
clude parthenolide and tanetin. There has been some 
scientific interest in parthenolide, which has been 
shown to induce apoptosis in some cancer cell lines 
in vitro and potentially to target cancer stem cells 
(Guzman and Jordan, 2005; Guzman et al., 2005; Le-
siak et al., 2010). Our results showed that Tanaceti 708 DESANKA CENIĆ-MILOŠEVIĆ ET AL.
Table 1. Concentrations of extracts that induced a 50% decrease in HeLa cell survival
Extracts HeLa IC50* 
Tanaceti partheni 153.71 ± 0.02 μg/ml
Hypericum perforatum > 200 μg/ml
Propolis 1.08 ± 0.01 mg/ml
Note: *IC50 values were obtained from the filtered extract suspensions. IC50 values were expressed as the mean ± SD determined from 
the results of MTT assay in three independent experiments. 
Fig. 1. (A, B). Representative graph of HeLa cells survival after 72 h cell growth in the presence of increasing concentrations of investi-
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partheni extract at a concentration of about 153µg/ml 
(153.71 ± 0.02) inhibited HeLa cell survival by 50% 
compared with a vehicle-treated control. The percent 
of parthenolide was 0.78% in the extract of Tanaceti 
partheni used. (The percentage of parthenolide was 
determined by quantitative HPLC analysis.
Hypericum is widely known as herbal treatment 
for depression and it may be useful in treating infect-
ed wounds and inflammatory skin diseases (Reutera 
et al., 2008). A major constituent chemical, hyper-
forin, may be useful in the treatment of alcoholism, 
although dosage, safety and efficacy have not been 
studied (Kumar et al., 2006; Reutera et al., 2008). Hy-
perforin has also displayed antibacterial properties 
against  Gram-negative  bacteria,  although  dosage, 
safety and efficacy have not been studied (Cecchini 
et al., 2007). Traditional medicine has also employed 
lipophilic extracts from Hypericum as a topical rem-
edy for wounds, abrasions, burns and muscle pain 
(Reutera et al., 2008). The positive effects that have 
been observed are generally attributed to hyperforin 
due to its possible antibacterial and anti-inflamma-
tory effects (Reutera et al., 2008). For this reason, hy-
perforin may be useful in the treatment of infected 
wounds and inflammatory skin diseases (Reutera et 
al., 2008). Hypericum contains various polyphenols: 
flavonoids (epigallocatechin, rutin, hyperoside, iso-
quercetin, quercitrin, quercetin, I3, II8-biapigenin, 
amentoflavone,  astilbin,  miquelianin)  (Yun  et  al., 
2009),  phenolic  acids  (chlorogenic  acid,  3-O-cou-
maroylquinic acid) and various naphtodianthrones 
(hypericin,  pseudohypericin,  protohypericin,  pro-
topseudohypericin),  phloroglucinols  (hyperforin, 
adhyperforin).  The  naphthodianthrones,  hypericin 
and pseudohypericin along with the phloroglucinol 
derivative hyperforin are thought to be active com-
ponents (Umek et al., 1999; Schwob et al., 2002; Tat-
sis et al., 2007). The percentage content of hypericin 
in  the  used  extract  of  Hypericum  perforatum  was 
0.31%. Hypericin complexes are characterized by red 
staining, which can be used directly for quantitative 
photometric determination (described in Deutsche 
Arzneimittel Codex-DAC).
Fig. 2. Light microscopy of HeLa cells cultured with or without the 200µg/ml of extracts: A) control; B) Tanaceti partheni; C) Hyperi-
cum perforatum and D) Propolis (2.0 mg/ml of extract) as described in Materials and Methods and photographed 72 h after addition of 
drugs (Magnification 12.5X, 1.6X, 6.3/0.2). 710 DESANKA CENIĆ-MILOŠEVIĆ ET AL.
Hypericum perforatum at concentrations greater 
than 200µg/ml inhibited HeLa cell survival by 50% 
compared with a vehicle-treated control. These re-
sults are not in correlation with the results of the 
other authors regarding the antiproliferative effects 
of Hypericum. Ferraz et al. (2005) evaluated the cy-
totoxic activity of the crude methanolic extracts of 
six Hypericum species. Antiproliferative assays using 
HT-29 human colon carcinoma cells and H-460 non-
small cell lung carcinoma were performed. However, 
the authors found that the most active crude extracts 
(100 µg/ml) were those of Hypericum caprifoliatum, 
Hypericum myrianthum and to a lesser extent Hy-
pericum  connatum.  The  differences  between  their 
results and ours are probably due to the use of dif-
ferent Hypericum species and different human cancer 
cell lines. 
Propolis is a natural, resinous hive product that 
honeybees manufacture by mixing their own wax and 
salivated secretions with resins collected from cracks 
in the bark of trees and leaf buds (Burdock, 1998; 
Banskota et al., 2001; Santos et al., 2003; Nakajima 
et al., 2009). The chemical composition of propolis 
depends on the vegetation, climate, season and envi-
ronmental conditions of the area from where it was 
collected (Santos et al., 2003; Viuda-Martos et al., 
2008). It is mainly composed of resin and vegetable 
balsam (50%), wax (30%), essential and aromatic oils 
(10%), pollen (5%), and various other substances, in-
cluding organic compounds and minerals (5%) (Bur-
dock, 1998; Viuda-Martos et al., 2008; Tylkowski et 
al., 2010). Organic compounds that are identified in 
different propolis samples are fatty and phenolic ac-
ids and esters, substituted phenolic esters, flavonoids 
(flavones, flavanones, dihydroflavonols, chalcones), 
terpenes, β-steroids, aromatic aldehydes and alco-
hols, sesquiterpenes, naphthalene and stilbene de-
rivatives (Marcucci et al., 2001; Valente et al., 2011). 
Propolis has a long history of use in folk medicine as 
an antimicrobial, antitumor, antibacterial, antifun-
gal, antiviral, anti-inflammatory, anti-oxidant, anti-
cancer, antiprotozoan, cariostatic, hepatoprotective 
and immunostimulant natural product (Banskota et 
al., 2001; Santos et al., 2003; Sforcin, 2007; Ivancajic 
et al., 2010; Valente et al., 2011). Numerous studies 
have been conducted to investige the antiprolifera-
tive effects of propolis. In vitro cytotoxicity against 
human fibrosarcoma, human lung carcinoma, and 
murine  colon  carcinoma  cells  has  been  demon-
strated by propolis and attributed to its benzofuran 
derivatives  (Banskota  et  al.,  1998;  Banskota  et  al., 
2000a; Banskota et al., 2000b, Hirota et al., 2000). 
Other constituents such as artepillin C and diethyl 
ether have demonstrated cytostatic activity against 
myeloid cell lines (Hladon et al., 1980; Kimoto et 
al., 2001; Ahn et al., 2007). Significant results have 
been seen against T-cell lines (Kimoto et al., 2001). 
Furthermore, Takara et al. (2007) investigated that 
in HeLa cells the sensitivity to paclitaxel and doxo-
rubicin, substrates of MDR1, was unchanged in the 
presence of propolis, while in HeLa/TXL cells, prop-
olis increased sensitivity to these MDR1 substrates. 
The authors suggested that the extract inhibited the 
function of MDR1 and increased the sensitivity to 
MDR1 substrates in HeLa/TXL cells. According to 
results of this study, the ethanolic extract of propolis 
collected from one bee colony (region of Raška) dur-
ing one time-frame (autumn), at a concentration of 
1 mg/ml (1.08±0.01) inhibited HeLa cell survival by 
50%. The weak antiproliferative effect of propolis on 
HeLa cells is perhaps a consequence of using a low 
concentration of propolis extracted in weakly polar 
solvents or because the propolis was collected in the 
autumn.
CONCLUSIONS
The extract of Tanaceti partheni exhibited mild cyto-
toxic activity. The extracts of Hypericum perforatum 
and propolis did not show active cytotoxic activity 
against the HeLa cell lines.
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